The influence of the MAPK pathway on T cell lineage commitment

Immunity. 1997 Nov;7(5):609-18. doi: 10.1016/s1074-7613(00)80382-9.

Abstract

During development, progenitor thymocytes differentiate into either CD4 or CD8 T cells, and this fate decision depends on the specificity of the T cell antigen receptor (TCR) for MHC class II or class I molecules. Based on the mechanisms of fate specification known for simple metazoan organisms, we sought to determine whether the extracellular signal-related kinases (ERKs) play a role in T cell differentiation and lineage commitment. Using a dominant gain-of-function mutant of the erk2 gene, we show that differentiation into the CD4 lineage is favored. We also show that, conversely, the addition of a pharmacological inhibitor of the ERK pathway favors differentiation into the CD8 lineage. We present a quantitative selection model that incorporates these results as well as those of recent reports on the role of Notch in T cell lineage specification.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Calcium-Calmodulin-Dependent Protein Kinases / antagonists & inhibitors
  • Calcium-Calmodulin-Dependent Protein Kinases / physiology*
  • Cell Differentiation
  • Cells, Cultured
  • Enzyme Activation / drug effects
  • Enzyme Inhibitors / pharmacology
  • Female
  • Flavonoids / pharmacology
  • Lymph Nodes / cytology
  • Lymphocyte Activation
  • Male
  • Membrane Proteins / physiology
  • Mice
  • Mice, Transgenic
  • Mitogen-Activated Protein Kinase 1
  • Receptors, Antigen, T-Cell, alpha-beta / genetics
  • Receptors, Notch
  • Signal Transduction / drug effects
  • T-Lymphocyte Subsets / cytology
  • T-Lymphocytes / cytology*
  • T-Lymphocytes / enzymology
  • Thymus Gland / cytology*

Substances

  • Enzyme Inhibitors
  • Flavonoids
  • Membrane Proteins
  • Receptors, Antigen, T-Cell, alpha-beta
  • Receptors, Notch
  • Calcium-Calmodulin-Dependent Protein Kinases
  • Mitogen-Activated Protein Kinase 1
  • 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one